TMT1A
Thiol S-methyltransferase TMT1A
Also known as: DKFZP586A0522, METTL7A, TMT1A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H8H3
- Gene
- TMT1A
- Ensembl
- ENSG00000185432
- Chromosome
- 12
- Canonical length
- 244 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Lipid droplets
OverviewNCBI Gene
Enables mRNA m(6)A methyltransferase activity and thiol S-methyltransferase activity. Involved in lncRNA processing; odontogenesis; and osteoblast differentiation. Located in endoplasmic reticulum and lipid droplet. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
244 residues, UniProt reviewed canonical sequence.
>Q9H8H3|TMT1A
1 MELTIFILRL AIYILTFPLY LLNFLGLWSW ICKKWFPYFL VRFTVIYNEQ MASKKRELFS
61 NLQEFAGPSG KLSLLEVGCG TGANFKFYPP GCRVTCIDPN PNFEKFLIKS IAENRHLQFE
121 RFVVAAGENM HQVADGSVDV VVCTLVLCSV KNQERILREV CRVLRPGGAF YFMEHVAAEC
181 STWNYFWQQV LDPAWHLLFD GCNLTRESWK ALERASFSKL KLQHIQAPLS WELVRPHIYG
241 YAVKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMT1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 395 nTPM
Expression across tissuesHPA
Tissue
- liver: 395 nTPM
- thyroid gland: 225 nTPM
- adipose tissue: 133 nTPM
- kidney: 131 nTPM
- pancreas: 108 nTPM
- fallopian tube: 82 nTPM
Single-cell type
- ependymal cells: 131 nCPM
- astrocytes: 122 nCPM
- bergmann glia: 108 nCPM
- microglia: 106 nCPM
- papillary tip epithelial cells: 77 nCPM
- proximal tubule cells: 72 nCPM
Immune cell
- basophil: 95 nTPM
- eosinophil: 70 nTPM
- non-classical monocyte: 59 nTPM
- intermediate monocyte: 37 nTPM
- classical monocyte: 35 nTPM
- naive B-cell: 34 nTPM
Brain region
- midbrain: 191 nTPM
- medulla oblongata: 190 nTPM
- basal ganglia: 171 nTPM
- thalamus: 168 nTPM
- choroid plexus: 165 nTPM
- hypothalamus: 163 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.38
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.18
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- methyltransferase activity
- mRNA m(6)A methyltransferase activity
- RNA methyltransferase activity
- thiol S-methyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TMT1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMT1A as an antibody target. Whether an autoantibody or antibody against TMT1A could matter depends on whether native TMT1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMT1A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMT1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...